Landis John B. - Insider Non-Derivative Transactions at EyePoint Pharmaceuticals, Inc. (EYPT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 9, 2023, Landis John B.'s relationship to EyePoint Pharmaceuticals, Inc. (EYPT) is Director, and currently has 11,400 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other EYPT insiders.
Data Source: SEC.
Landis John B. - Insider Non-Derivative Transactions at EYPT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 10, 2023 | M -- (Common Stock) | 3000 | 0 | 11400 |